Platelet activation in patients with Familial Mediterranean Fever

References

• Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol 2000; 14: 477–498
   PubMed Web of Science ®Google Scholar
• Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, Kastner DL. Familial Mediterranean fever at the millenium. Clinical spectrum, ancient mutations and a survey of 100 American referrals to the National Instututes of Health. Medicine (Baltimore) 1998; 77: 268–297
   PubMed Web of Science ®Google Scholar
• Turkish FMF Study Group. Familial Mediterranean Fever (FMF) in Turkey Results of a Nationwide Multicenter Study. Medicine 2005; 84: 1–11
   PubMed Web of Science ®Google Scholar
• Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 2007; 65: 318–324
   PubMed Web of Science ®Google Scholar
• Peru H, Altun B, Dogan M, Kara F, Elmaci AM, Oran B. The evaluation of carotid intima-media thickness in children with familial Mediterranean fever. Clin Rheumatol 2008; 27: 689–694
   PubMed Web of Science ®Google Scholar
• Akdogan M, Calguneri M, Yavuz B, Arslan EB, Kalyoncu U, Sahiner L, Karadag O, Ertenli I, Kiraz S, Aytemir K. Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 2006; 48: 2351–2353
   PubMed Web of Science ®Google Scholar
• Caliskan M, Gullu H, Yilmaz S, Erdogan D, Unler GK, Ciftci O, Topcu S, Kayhan Z, Yucel E, Muderrisoglu H. Impaired coronary microvascular function in familial Mediterranean fever. Atherosclerosis 2007; 195: 161–167
   Web of Science ®Google Scholar
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity?. Clin Appl Thromb Hemost 2003; 9: 177–190
   PubMed Web of Science ®Google Scholar
• Thompson CB, Eaton K, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 1982; 50: 509–519
   PubMed Web of Science ®Google Scholar
• Park Y, Schoene N, Haris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002; 13: 301–306
   PubMed Web of Science ®Google Scholar
• Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002; 117: 399–404
   PubMed Web of Science ®Google Scholar
• Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409–1411
   PubMed Web of Science ®Google Scholar
• Tschoepe D, Esser J, Schwippert B, Rosen P, Kehrel B, Niewuenhuis HK, Gries FA. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 1991; 17: 433–439
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157–161
   PubMed Web of Science ®Google Scholar
• Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 1992; 14: 281–287
   PubMedGoogle Scholar
• Bath PM, Missouris CG, Buckenham T, MacGregor GA. Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis. Clin Sci (Lond) 1994; 87: 253–257
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879–1885
   PubMed Web of Science ®Google Scholar
• Lidar M, Scherrmann JM, Shinar Y, Chetrit A, Niel E, Gershoni-Baruch R, Langevitz P, Livneh A. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum 2004; 33: 273–282
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levi RI, Fredricksen DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Bath PM. The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost 1993; 70: 687–690
   PubMed Web of Science ®Google Scholar
• Hascard DO. Accelerated atherosclerosis in inflammatory rheumatic diseases. Scand J Rheumatol 2004; 33: 281–292
   PubMed Web of Science ®Google Scholar
• Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M, Akkoc N, Tunca M, Goktay Y, Onen F. Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 2007; 26: 1467–1473
   PubMed Web of Science ®Google Scholar